HAEMATO

HAEMATO AG is a German specialty pharmaceutical company focused on the procurement, development, and distribution of high-value medications for chronic diseases and medical aesthetics. The company operates primarily in the European market, specializing in therapeutic areas such as oncology, HIV, rheumatology, and neurology. HAEMATO's business model integrates the parallel import of branded pharmaceuticals with the commercialization of its own generic products and aesthetic medical devices, including botulinum toxin and dermal fillers. As a key subsidiary of M1 Kliniken AG, the company leverages its extensive distribution network to provide cost-effective treatment options to pharmacies and wholesalers. HAEMATO is publicly traded on the Frankfurt Stock Exchange and maintains a strong focus on the growing market for lifestyle and specialty healthcare products.